Merck MRK
NYSE MRK
$144.70 -2.83 (-1.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Merck (MRK) Intangibles (2009 - 2026)

Merck's (MRK) quarterly Intangibles came in at $25.0 billion in Q2 2026, up 64.4% year-over-year from $15.2 billion in Q2 2025, and down 2.98% quarter-over-quarter from $25.7 billion in Q1 2026.

Analysis

Merck (MRK) Intangibles (2009 - 2026) Analysis & Trends

Merck (MRK) has reported Intangibles for 18 consecutive years, with $25.0 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Intangibles rose 64.4% year-over-year to $25.0 billion in Q2 2026; TTM through Jun 2026 was $25.0 billion, a 64.4% increase from a year earlier, with the FY2025 full-year figure at $26.7 billion, up 62.99% from the prior year.
  • Intangibles was $25.0 billion for Q2 2026 at Merck, down from $25.7 billion in the prior quarter.
  • Over five years, Intangibles peaked at $26.7 billion in Q4 2025 and troughed at $15.2 billion in Q2 2025.
  • A 5-year average of $19.7 billion and a median of $19.4 billion in 2023 frame the typical range for Intangibles.
  • Across the five-year window, Intangibles surged 65.15% in 2022 and fell 13.75% in 2023, its largest moves.
  • Over 5 years, Intangibles stood at $20.3 billion in 2022, then retreated by 11.14% to $18.0 billion in 2023, then declined by 9.11% to $16.4 billion in 2024, then soared by 62.99% to $26.7 billion in 2025, then dropped by 6.38% to $25.0 billion in 2026.
  • The last three Intangibles figures came in at $25.0 billion (Q2 2026), $25.7 billion (Q1 2026), and $26.7 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 48.23 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 49.14 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 24.98 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 42.07 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 47.05 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 30.64 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - 63.28 Mn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 103.20 Mn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn -
10 Neurocrine Biosciences 15.82 Bn 15.43 Bn 935.80 Mn 2.23 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.98 Bn
Mar 31, 2026 25.75 Bn
Dec 31, 2025 26.68 Bn
Sep 30, 2025 15.31 Bn
Jun 30, 2025 15.19 Bn
Mar 31, 2025 15.76 Bn
Dec 31, 2024 16.37 Bn
Sep 30, 2024 17.01 Bn
Jun 30, 2024 16.98 Bn
Mar 31, 2024 17.57 Bn
Dec 31, 2023 18.01 Bn
Sep 30, 2023 19.20 Bn
Jun 30, 2023 19.67 Bn
Mar 31, 2023 19.86 Bn
Dec 31, 2022 20.27 Bn
Sep 30, 2022 21.37 Bn
Jun 30, 2022 22.50 Bn
Mar 31, 2022 23.02 Bn
Dec 31, 2021 22.93 Bn
Sep 30, 2021 13.38 Bn